Does BASILIXIMAB Cause Product use in unapproved indication? 428 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 428 reports of Product use in unapproved indication have been filed in association with BASILIXIMAB (Simulect). This represents 6.3% of all adverse event reports for BASILIXIMAB.
428
Reports of Product use in unapproved indication with BASILIXIMAB
6.3%
of all BASILIXIMAB reports
86
Deaths
79
Hospitalizations
How Dangerous Is Product use in unapproved indication From BASILIXIMAB?
Of the 428 reports, 86 (20.1%) resulted in death, 79 (18.5%) required hospitalization, and 22 (5.1%) were considered life-threatening.
Is Product use in unapproved indication Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BASILIXIMAB. However, 428 reports have been filed with the FAERS database.
What Other Side Effects Does BASILIXIMAB Cause?
Cytomegalovirus infection (590)
Drug ineffective (567)
Off label use (567)
Transplant rejection (554)
Kidney transplant rejection (456)
Pyrexia (323)
Diarrhoea (314)
Multiple organ dysfunction syndrome (298)
Polyomavirus-associated nephropathy (298)
Acute kidney injury (285)
What Other Drugs Cause Product use in unapproved indication?
DUPILUMAB (33,452)
DICLOFENAC (12,197)
METHOTREXATE (8,930)
PREDNISONE (7,625)
RITUXIMAB (7,519)
MYCOPHENOLATE MOFETIL (5,910)
ACETAMINOPHEN (5,819)
CYCLOPHOSPHAMIDE (5,750)
RISPERIDONE (5,551)
TACROLIMUS (5,057)
Which BASILIXIMAB Alternatives Have Lower Product use in unapproved indication Risk?
BASILIXIMAB vs BAYER GENUINE ASPIRIN ORIGINAL STRENGTH
BASILIXIMAB vs BAZEDOXIFENE\ESTROGENS, CONJUGATED
BASILIXIMAB vs BCG VACCINE
BASILIXIMAB vs BEBTELOVIMAB
BASILIXIMAB vs BECLOMETHASONE